ACOG (Alpha Cognition) 1-Year Sharpe Ratio: -0.35 (As of Jul. 11, 2026)


ACOG Alpha Cognition Inc ACOG
31 GF Score
Price $8.41
! 3 Warning Signs
View Full Analysis

What is Alpha Cognition 1-Year Sharpe Ratio?

Alpha Cognition ACOG -1.18% 31 1-Year Sharpe Ratio is -0.35 as of Jul. 11, 2026. GuruFocus rates ACOG with a GF Score™ of 31/100. The stock has 3 warning signs investors should review.

The 1-Year Sharpe Ratio measures the additional return that an investor receives per unit of increase in risk over the past year. As of today (2026-07-11), Alpha Cognition's 1-Year Sharpe Ratio is -0.35.

Alpha Cognition  (NAS:ACOG) 1-Year Sharpe Ratio Explanation

The 1-Year Sharpe Ratio inidicates the risk-adjusted return of an investment over the past year. It is calculated as the annualized result of the average monthly excess return divided by its standard deviation over the past year. The monthly excess return is the monthly investment return minus the monthly risk-free rate (typically the 10-year Treasury Constant Maturity Rate). If the risk-free rate for a specific region is not available, U.S. data is used by default.

The greater a portfolio's Sharpe Ratio, the better its risk-adjusted performance. A negative Sharpe Ratio means the risk-free rate is greater than the portfolio’s historical or projected return, or else the portfolio's return is expected to be negative.

Alpha Cognition 1-Year Sharpe Ratio Related Terms

ACOG vs HURA, MENS, ENLV: 1-Year Sharpe Ratio Comparison

For the Biotechnology subindustry, Alpha Cognition's 1-Year Sharpe Ratio, along with its competitors' market caps and 1-Year Sharpe Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Alpha Cognition 1-Year Sharpe Ratio vs Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Alpha Cognition's 1-Year Sharpe Ratio distribution charts can be found below:

* The bar in red indicates where Alpha Cognition's 1-Year Sharpe Ratio falls into.


ACOG
31GF Score
Alpha Cognition Inc ACOG
1-Year Sharpe Ratio is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Alpha Cognition 1-Year Sharpe Ratio Calculation

The 1-Year Sharpe Ratio measures the performance of an investment such as a stock or portfolio compared to a risk-free asset. A stock / portfolio's 1-Year Sharpe Ratio can be calculated by dividing the difference between the one-year returns of the investment and the risk-free rate, by the standard deviation of the investment returns over one year.

Frequently Asked Questions Learn more about 1-Year Sharpe Ratio →
What does a 1-Year Sharpe Ratio of -0.35 mean?
Alpha Cognition (ACOG) has a 1-Year Sharpe Ratio of -0.35 as of Jul. 11, 2026. 1-Year Sharpe Ratio measures the additional return that an investor receives per unit of increase in risk. View historical data for Alpha Cognition and its competitors.
Is Alpha Cognition's 1-Year Sharpe Ratio too high?
Alpha Cognition's current 1-Year Sharpe Ratio is -0.35. Overall, Alpha Cognition has a GF Score™ of 31/100, reflecting its overall financial health beyond just this single metric.
How does Alpha Cognition's 1-Year Sharpe Ratio compare to HURA and MENS?
Alpha Cognition's 1-Year Sharpe Ratio of -0.35 can be compared against companies in the Biotechnology industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good 1-Year Sharpe Ratio for a Biotechnology company?
A good 1-Year Sharpe Ratio depends on the Biotechnology industry context. However, 1-Year Sharpe Ratio should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high 1-Year Sharpe Ratio mean?
A high 1-Year Sharpe Ratio can signal that a stock is expensive relative to its fundamentals. 1-Year Sharpe Ratio measures the additional return that an investor receives per unit of increase in risk. View historical data for Alpha Cognition and its competitors. Alpha Cognition's current 1-Year Sharpe Ratio is -0.35. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Alpha Cognition stock overvalued right now?
Alpha Cognition (ACOG) has a current 1-Year Sharpe Ratio of -0.35. The current 1-Year Sharpe Ratio is -0.35. Alpha Cognition's overall GF Score™ is 31/100 with 3 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is 1-Year Sharpe Ratio calculated?
1-Year Sharpe Ratio is calculated from a company's financial statements. For Alpha Cognition (ACOG), the current 1-Year Sharpe Ratio is -0.35 as of Jul. 11, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Alpha Cognition Business Description

Other Exchanges 7N70:Germany
Address 1200 - 750 West Pender Street, Vancouver, BC, CAN, V6C 2T8
Alpha Cognition Inc is a biopharmaceutical company dedicated to developing treatments for patients suffering from neurodegenerative diseases, such as Alzheimers disease, for which there are limited or no treatment options. The Companies current focus is on the commercial manufacturing and sales of ZUNVEYL oral tablet formulation. The Companies commercial development program for ZUNVEYL is focused on building a long-term care commercial team that can focus on providing key points of differentiation, exploiting key issues with existing Acetylcholinesterase inhibitors treatments, and seeking potential licensing partners for other additional indications and new formulations.
31GF Score

Get the complete analysis for ACOG

1-Year Sharpe Ratio is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

$8.41
Price